These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18832099)

  • 1. Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs.
    Ben-Jonathan N; Chen S; Dunckley JA; LaPensee C; Kansra S
    Endocrinology; 2009 Feb; 150(2):795-802. PubMed ID: 18832099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.
    Chen S; Bangaru ML; Sneade L; Dunckley JA; Ben-Jonathan N; Kansra S
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E331-9. PubMed ID: 19470835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor induces a sexually dimorphic proliferative response of lactotroph cells through protein kinase C-ERK1/2-Pit-1 in vitro.
    De Paul AL; Gutiérrez S; Sabatino ME; Mukdsi JH; Palmeri CM; Soaje M; Petiti JP; Torres AI
    Exp Physiol; 2011 Feb; 96(2):226-39. PubMed ID: 21075822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
    Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
    Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of ligand-independent transcriptional activation of the estrogen receptor via the estrogen response element in pituitary lactotrophs in primary culture.
    Ishida M; Mitsui T; Izawa M; Arita J
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):93-101. PubMed ID: 19883758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.
    Ishida M; Mitsui T; Izawa M; Arita J
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):58-67. PubMed ID: 23701824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
    Kansra S; Yamagata S; Sneade L; Foster L; Ben-Jonathan N
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):27-36. PubMed ID: 15950373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.
    Kansra S; Chen S; Bangaru ML; Sneade L; Dunckley JA; Ben-Jonathan N
    PLoS One; 2010 Apr; 5(4):e10060. PubMed ID: 20419096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture.
    Ishida M; Mitsui T; Yamakawa K; Sugiyama N; Takahashi W; Shimura H; Endo T; Kobayashi T; Arita J
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1529-37. PubMed ID: 17925456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of implantation potential in mouse blastocysts derived from IVF by combined treatment with prolactin, epidermal growth factor and 4-hydroxyestradiol.
    Takeuchi M; Seki M; Furukawa E; Takahashi A; Saito K; Kobayashi M; Ezoe K; Fukui E; Yoshizawa M; Matsumoto H
    Mol Hum Reprod; 2017 Aug; 23(8):557-570. PubMed ID: 28810691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and signaling of G protein-coupled estrogen receptor 1 (GPER) in rat sertoli cells.
    Lucas TF; Royer C; Siu ER; Lazari MF; Porto CS
    Biol Reprod; 2010 Aug; 83(2):307-17. PubMed ID: 20445128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadmium mimics estrogen-driven cell proliferation and prolactin secretion from anterior pituitary cells.
    Ronchetti SA; Miler EA; Duvilanski BH; Cabilla JP
    PLoS One; 2013; 8(11):e81101. PubMed ID: 24236210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen actions on lactotroph proliferation are independent of a paracrine interaction with other pituitary cell types: a study using lactotroph-enriched cells.
    Ishida M; Takahashi W; Itoh S; Shimodaira S; Maeda S; Arita J
    Endocrinology; 2007 Jul; 148(7):3131-9. PubMed ID: 17412817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of insulin-like growth factor-I and estrogen on prolactin cells in the mouse anterior pituitary.
    Hikake T; Hayashi S; Chambon P; Watanabe H; Iguchi T; Sato T
    Exp Biol Med (Maywood); 2010 Aug; 235(8):974-80. PubMed ID: 20576740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.